On Wednesday, the Advisory Committee on Immunization Practices (ACIP) voted to expand its recommendation for the use of ...

Pfizer's Abrysvo and GSK's Arexvy both received FDA-approval b in 2024 to include immunization of adults aged 50 to 59 years at increased risk for RSV disease.

The CPS-Ped may be an efficient outcome metric for monitoring disease severity and clinical improvement over time among infants with RSV-related critical illness.

A CDC committee has voted to expand its respiratory syncytial virus vaccine recommendation to include all people aged 50 to ...

The Advisory Committee on Immunization Practices convened to make expanded vaccine recommendations amidst CDC leadership changes.

Elgin Community College will hold a Thriving After 55 resource fair on Friday, April 25. The free event will be from 10 a.m. to 2 p.m. at Building J on the campus at 1700 Spartan Dr. It is tailored ...

A new AAA Foundation for Traffic Safety (FTS) report researches and provides suggestions for how tow trucks and other ...

The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices voted to expand access to Pfizer’s respiratory syncytial virus vaccine Abrysvo for high-risk adults in ...

A federal panel of medical experts on Wednesday recommended an expansion of RSV vaccinations for adults and a new combination shot as another option to protect teens against meningitis. The 15-member ...

In a statement today, GlaxoSmithKline Malaysia (GSK) highlighted that RSV is a common and highly contagious virus that can lead to serious health complications, including lower respiratory tract ...

China is not as big a player in the manufacturing of key ingredients used to make brand and generic medicines as previously ...

A HORRIFIED dad has spoken of how he has watched not one daughter, but both fight for their lives in hospital. “It turns out ...